Atlas Capital Advisors’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.77K | Hold |
138
| – | – | ﹤0.01% | 867 |
|
|
2025
Q1 | $1.75K | Hold |
138
| – | – | ﹤0.01% | 909 |
|
|
2024
Q4 | $1.81K | Buy |
+138
| New | +$1.81K | ﹤0.01% | 873 |
|
|
2024
Q3 | – | Sell |
-138
| Closed | -$1.96K | – | 934 |
|
|
2024
Q2 | $1.96K | Buy |
+138
| New | +$1.96K | ﹤0.01% | 828 |
|
|
2024
Q1 | – | Sell |
-138
| Closed | -$1.86K | – | 927 |
|
|
2023
Q4 | $1.86K | Hold |
138
| – | – | ﹤0.01% | 833 |
|
|
2023
Q3 | $1.72K | Hold |
138
| – | – | ﹤0.01% | 814 |
|
|
2023
Q2 | $1.87K | Hold |
138
| – | – | ﹤0.01% | 826 |
|
|
2023
Q1 | $1.92K | Hold |
138
| – | – | ﹤0.01% | 836 |
|
|
2022
Q4 | $1.96K | Hold |
138
| – | – | ﹤0.01% | 832 |
|
|
2022
Q3 | $1.89K | Hold |
138
| – | – | ﹤0.01% | 837 |
|
|
2022
Q2 | $1.96K | Buy |
+138
| New | +$1.96K | ﹤0.01% | 909 |
|